Difference between revisions of "Houseknecht KL, et al. Domest. Anim. Endocrinol. (2002) cited as Ref 384 in DOI: 10.1038/s41392-020-0110-5 (Q9647)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 22, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review (English) | ||
| Property / title: Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:00, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Houseknecht KL, et al. Domest. Anim. Endocrinol. (2002) cited as Ref 384 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Houseknecht KL
0 references
Cole BM
0 references
Steele PJ
0 references
2002
0 references
Domest. Anim. Endocrinol.
0 references
22
0 references
Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review (English)
0 references
